. .

Canada’s first Magnetic Particle Imaging system finds a home at Robarts

Considered the most promising and emerging imaging technology of the past 20 years, Magnetic Particle Imaging (MPI) provides unique research opportunities for cancer and neurological and vascular conditions.

Meet a researcher: John Ronald, PhD

Imaging scientist John Ronald, PhD, is leading the way to more personalized cancer treatment, using gene editing technology and non-invasive imaging to track and monitor cell-based cancer treatments.

Diabetes medication shows potential to reduce heart disease

A new study from David Hess, PhD, and clinical collaborators sheds light on how a class of medications that help regulate blood sugar for patients with Type 2 diabetes can also protect against heart disease.

Impact of vaping on people’s lungs

Imaging scientist Grace Parraga, PhD, sounds the alarm about the harmful effects of vaping in a commentary.

Scientific Director's Update

Maximizing the promise of basic science research

How can we speed up the process linking basic research discoveries to new tools in the arsenal of patient care? At Robarts, we are working to accelerate and maximize the impact of basic science discoveries with a bold new initiative.

Latest News

New Canada Research Chairs, national honours and research investments

Three Robarts scientists were named among Canada’s most accomplished and promising minds, while others received national honours and new research funding.

The Next Generation

Inspiring the future of cancer research

Claire Park is developing an image-guided biopsy system to better detect and diagnose breast cancer. The PhD Candidate is working with renowned scientist and mentor Aaron Fenster, PhD.

Upcoming Events

Looking toward a healthier future

Don’t miss out on meeting and hearing from researchers who are developing therapeutic strategies for central nervous system repair, working together to calm a racing heart and closing in on a cure for diabetes. Register today for Discover Robarts.